Cargando…
Heterologous prime-boost cellular vaccination induces potent antitumor immunity against triple negative breast cancer
INTRODUCTION: Triple negative breast cancer (TNBC) is the most aggressive and hard-to-treat subtype of breast cancer, affecting 10-20% of all women diagnosed with breast cancer. Surgery, chemotherapy and hormone/Her2 targeted therapies are the cornerstones of treatment for breast cancer, but women w...
Autores principales: | Niavarani, Seyedeh-Raheleh, St-Cyr, Guillaume, Daniel, Lauren, Lawson, Christine, Giguère, Hugo, Alkayyal, Almohanad A., Tai, Lee-Hwa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968850/ https://www.ncbi.nlm.nih.gov/pubmed/36860852 http://dx.doi.org/10.3389/fimmu.2023.1098344 |
Ejemplares similares
-
Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs
por: St-Cyr, Guillaume, et al.
Publicado: (2023) -
Oncolytic vesicular stomatitis virus–based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8(+) T-cell functionality
por: Niavarani, Seyedeh-Raheleh, et al.
Publicado: (2020) -
Treatment of Metastatic Disease through Natural Killer Cell Modulation by Infected Cell Vaccines
por: Niavarani, Seyedeh Raheleh, et al.
Publicado: (2019) -
Heterologous prime boost COVID 19 vaccination
por: Launay, O., et al.
Publicado: (2022) -
Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period
por: Niavarani, Seyedeh Raheleh, et al.
Publicado: (2019)